Study Details

General Information

NuSirt Biopharma DM2 NS-0100-01

A Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effect of Various Fixed-Dose Lueucine and Metformin Combinations (NS-0100) versus Standard Metformin Monotherapy on Glycemic Control in Subjects with Type 2 Diabetes.

ProtocolNS-0100-01
IdentifierNS-0100-01 Site Number: 08
UID393e6965-b9e9-44b9-8427-e8cea67cf880
StatusDone - Archived
Phase2A
CategoryDiabetes Type 2 / Adult
Launch Year2014
NCT Number-
Created2014-06-27 17:14
Last Updated2014-06-27 17:14

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2015-04-09No
Enrollment Open2014-08-25No
First Patient First VisitNo
Site Initiation Mtg.2014-08-11No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2016-04-14No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMoon, MiaMMoonNo
Recruiter-No
CoordinatorValenzuela, LouisitoLValenzuelaNo
RegulatoryPerez, MyrnaMPerezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorNuSirt BioPharma
DivisionNuSirt BioPharma
TeamNuSirt BioPharma
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?